.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Mallinckrodt
US Army
Harvard Business School
Medtronic
QuintilesIMS
Cipla
Express Scripts
Accenture
Queensland Health

Generated: September 19, 2017

DrugPatentWatch Database Preview

PROCAINAMIDE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Procainamide Hydrochloride, and when can generic versions of Procainamide Hydrochloride launch?

Procainamide Hydrochloride is a drug marketed by Watson Labs, Ivax Sub Teva Pharms, Ani Pharms Inc, Abraxis Pharm, Idt Australia Ltd, Pharmafair, Warner Chilcott, West-ward Pharms Int, Smith And Nephew, Solopak, Intl Medication, Hospira, Inwood Labs, Ascot, Lederle, Vangard, Sandoz, Roxane, and Lannett. and is included in fifty-seven NDAs.

The generic ingredient in PROCAINAMIDE HYDROCHLORIDE is procainamide hydrochloride. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.

Summary for Tradename: PROCAINAMIDE HYDROCHLORIDE

Patents:0
Applicants:19
NDAs:57
Suppliers / Packagers: see list4
Bulk Api Vendors: see list55
Clinical Trials: see list2,286
Patent Applications: see list986
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROCAINAMIDE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: PROCAINAMIDE HYDROCHLORIDE

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL088959-001Dec 2, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Ascot
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL087542-001Jan 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vangard
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL087875-001Jun 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL084696-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Idt Australia Ltd
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL089369-002Jan 9, 1987RXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
INJECTABLE;INJECTION087079-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roxane
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL088989-001Apr 26, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Ascot
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL087697-001Mar 1, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
INJECTABLE;INJECTION089537-001Aug 25, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
PROCAINAMIDE HYDROCHLORIDE
procainamide hydrochloride
CAPSULE;ORAL086942-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Queensland Health
Harvard Business School
Baxter
Cerilliant
Cantor Fitzgerald
Teva
Covington
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot